Cytosorbents Corporation (CTSO)
USD 0.86
(5.91%)
USD 0.86
(5.91%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 29.98 Million USD | 7.64% |
| 2022 | 27.85 Million USD | 3.4% |
| 2021 | 26.94 Million USD | 150.96% |
| 2020 | 10.73 Million USD | -55.21% |
| 2019 | 23.96 Million USD | 51.56% |
| 2018 | 15.81 Million USD | 14.25% |
| 2017 | 13.84 Million USD | 36.12% |
| 2016 | 10.16 Million USD | 234.06% |
| 2015 | 3.04 Million USD | -32.45% |
| 2014 | 4.5 Million USD | -75.39% |
| 2013 | 18.31 Million USD | 22.36% |
| 2012 | 14.96 Million USD | 729.43% |
| 2011 | 1.8 Million USD | -21.44% |
| 2010 | 2.29 Million USD | 136.57% |
| 2009 | 970.76 Thousand USD | -5.54% |
| 2008 | 1.02 Million USD | 13.32% |
| 2007 | 906.86 Thousand USD | -16.19% |
| 2006 | 1.08 Million USD | 1102.27% |
| 2005 | 90 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 28.14 Million USD | -6.15% |
| 2024 Q2 | 36.69 Million USD | 30.37% |
| 2023 FY | 29.98 Million USD | 7.64% |
| 2023 Q4 | 29.98 Million USD | 3.17% |
| 2023 Q3 | 29.06 Million USD | 2.51% |
| 2023 Q2 | 28.35 Million USD | -0.55% |
| 2023 Q1 | 28.5 Million USD | 2.34% |
| 2022 Q4 | 27.85 Million USD | 20.44% |
| 2022 Q1 | 27.84 Million USD | 3.35% |
| 2022 FY | 27.85 Million USD | 3.4% |
| 2022 Q2 | 23.64 Million USD | -15.08% |
| 2022 Q3 | 23.12 Million USD | -2.19% |
| 2021 Q1 | 10.22 Million USD | -4.79% |
| 2021 FY | 26.94 Million USD | 150.96% |
| 2021 Q2 | 23.8 Million USD | 132.95% |
| 2021 Q3 | 24.45 Million USD | 2.72% |
| 2021 Q4 | 26.94 Million USD | 10.16% |
| 2020 Q3 | 24.04 Million USD | -3.56% |
| 2020 FY | 10.73 Million USD | -55.21% |
| 2020 Q1 | 22.91 Million USD | -4.39% |
| 2020 Q2 | 24.93 Million USD | 8.84% |
| 2020 Q4 | 10.73 Million USD | -55.36% |
| 2019 Q4 | 23.96 Million USD | 9.19% |
| 2019 Q3 | 21.94 Million USD | 29.56% |
| 2019 Q2 | 16.94 Million USD | 6.01% |
| 2019 Q1 | 15.97 Million USD | 1.06% |
| 2019 FY | 23.96 Million USD | 51.56% |
| 2018 Q1 | 13.85 Million USD | 0.11% |
| 2018 Q3 | 14.17 Million USD | 5.93% |
| 2018 Q4 | 15.81 Million USD | 11.52% |
| 2018 FY | 15.81 Million USD | 14.25% |
| 2018 Q2 | 13.38 Million USD | -3.4% |
| 2017 Q4 | 13.84 Million USD | 8.6% |
| 2017 Q2 | 14.17 Million USD | 43.72% |
| 2017 FY | 13.84 Million USD | 36.12% |
| 2017 Q1 | 9.85 Million USD | -3.03% |
| 2017 Q3 | 12.74 Million USD | -10.06% |
| 2016 Q4 | 10.16 Million USD | 7.27% |
| 2016 FY | 10.16 Million USD | 234.06% |
| 2016 Q3 | 9.47 Million USD | 7.54% |
| 2016 Q2 | 8.81 Million USD | 171.34% |
| 2016 Q1 | 3.24 Million USD | 6.72% |
| 2015 Q4 | 3.04 Million USD | -11.69% |
| 2015 FY | 3.04 Million USD | -32.45% |
| 2015 Q1 | 6.19 Million USD | 37.58% |
| 2015 Q2 | 2.52 Million USD | -59.22% |
| 2015 Q3 | 3.44 Million USD | 36.35% |
| 2014 Q3 | 20.42 Million USD | -0.31% |
| 2014 FY | 4.5 Million USD | -75.39% |
| 2014 Q4 | 4.5 Million USD | -77.94% |
| 2014 Q1 | 19.65 Million USD | 7.32% |
| 2014 Q2 | 20.48 Million USD | 4.25% |
| 2013 Q1 | 14.46 Million USD | -3.35% |
| 2013 FY | 18.31 Million USD | 22.36% |
| 2013 Q2 | 16.16 Million USD | 11.77% |
| 2013 Q3 | 17.64 Million USD | 9.17% |
| 2013 Q4 | 18.31 Million USD | 3.75% |
| 2012 FY | 14.96 Million USD | 729.43% |
| 2012 Q1 | 2.24 Million USD | 24.64% |
| 2012 Q4 | 14.96 Million USD | 620.92% |
| 2012 Q3 | 2.07 Million USD | -9.92% |
| 2012 Q2 | 2.3 Million USD | 2.47% |
| 2011 Q4 | 1.8 Million USD | -0.51% |
| 2011 Q1 | 1.72 Million USD | -24.93% |
| 2011 Q2 | 1.94 Million USD | 12.83% |
| 2011 Q3 | 1.81 Million USD | -6.77% |
| 2011 FY | 1.8 Million USD | -21.44% |
| 2010 Q3 | 2.03 Million USD | 66.45% |
| 2010 FY | 2.29 Million USD | 136.57% |
| 2010 Q4 | 2.29 Million USD | 12.69% |
| 2010 Q1 | 1.32 Million USD | 36.05% |
| 2010 Q2 | 1.22 Million USD | -7.3% |
| 2009 Q4 | 970.76 Thousand USD | 6.0% |
| 2009 FY | 970.76 Thousand USD | -5.54% |
| 2009 Q2 | 919.81 Thousand USD | 2.99% |
| 2009 Q3 | 915.83 Thousand USD | -0.43% |
| 2009 Q1 | 893.06 Thousand USD | -13.1% |
| 2008 Q1 | 1.23 Million USD | 36.54% |
| 2008 Q4 | 1.02 Million USD | 4.6% |
| 2008 Q3 | 982.5 Thousand USD | -19.91% |
| 2008 Q2 | 1.22 Million USD | -0.92% |
| 2008 FY | 1.02 Million USD | 13.32% |
| 2007 Q2 | 1.53 Million USD | 6.72% |
| 2007 Q1 | 1.43 Million USD | 32.59% |
| 2007 FY | 906.86 Thousand USD | -16.19% |
| 2007 Q4 | 906.86 Thousand USD | 3.95% |
| 2007 Q3 | 872.42 Thousand USD | -43.02% |
| 2006 Q4 | 1.08 Million USD | -54.87% |
| 2006 Q3 | 2.39 Million USD | -34.94% |
| 2006 Q2 | 3.68 Million USD | 3236.35% |
| 2006 FY | 1.08 Million USD | 1102.27% |
| 2006 Q1 | 110.45 Thousand USD | 8.32% |
| 2005 Q4 | 101.97 Thousand USD | 8.56% |
| 2005 Q3 | 93.93 Thousand USD | 4.37% |
| 2005 Q1 | 70 Thousand USD | 600.0% |
| 2005 FY | 90 Thousand USD | 0.0% |
| 2005 Q2 | 90 Thousand USD | 28.57% |
| 2004 Q4 | 10 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 45.321% |
| Axonics, Inc. | 82.35 Million USD | 63.592% |
| INVO Bioscience, Inc. | 19.99 Million USD | -49.965% |
| CVRx, Inc. | 39.28 Million USD | 23.666% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 86.556% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -842.364% |
| MaxCyte, Inc. | 36.1 Million USD | 16.954% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -39.545% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 75.811% |
| Sintx Technologies, Inc. | 6.59 Million USD | -354.808% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 41.496% |
| Apyx Medical Corporation | 52.31 Million USD | 42.686% |
| Cutera, Inc. | 518.12 Million USD | 94.213% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -461.315% |
| NeuroPace, Inc. | 86.99 Million USD | 65.533% |
| IRIDEX Corporation | 24.91 Million USD | -20.356% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 65.846% |
| enVVeno Medical Corporation | 2.43 Million USD | -1131.436% |
| TELA Bio, Inc. | 59.16 Million USD | 49.321% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 95.308% |
| UFP Technologies, Inc. | 118.04 Million USD | 74.598% |
| Modular Medical, Inc. | 2.27 Million USD | -1219.783% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -2.242% |
| LENSAR, Inc. | 22.4 Million USD | -33.81% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.633% |
| Surmodics, Inc. | 65.82 Million USD | 54.445% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -190.585% |
| Inogen, Inc. | 121.38 Million USD | 75.297% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1691.247% |
| RxSight, Inc. | 22.18 Million USD | -35.143% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6950.743% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -1.367% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -29.616% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6950.743% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1134.326% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 71.335% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 95.738% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -17.761% |
| Dynatronics Corporation | 11.78 Million USD | -154.543% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 41.959% |
| InMode Ltd. | 75.91 Million USD | 60.501% |
| Bruker Corporation | 2.83 Billion USD | 98.943% |
| Movano Inc. | 5.97 Million USD | -402.101% |
| Orthofix Medical Inc. | 326.58 Million USD | 90.818% |
| FONAR Corporation | 57.45 Million USD | 47.813% |
| BioSig Technologies, Inc. | 4.68 Million USD | -540.031% |
| Envoy Medical, Inc. | 9.4 Million USD | -218.927% |
| Align Technology, Inc. | 2.45 Billion USD | 98.778% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 48.626% |
| Talis Biomedical Corporation | 29.22 Million USD | -2.606% |
| Cerus Corporation | 144.3 Million USD | 79.221% |
| 908 Devices Inc. | 37.49 Million USD | 20.017% |
| Nemaura Medical Inc. | 26.37 Million USD | -13.679% |
| Outset Medical, Inc. | 190.91 Million USD | 84.294% |
| NanoVibronix, Inc. | 2.68 Million USD | -1016.362% |
| Venus Concept Inc. | 107.1 Million USD | 72.003% |
| Telesis Bio, Inc. | 40.87 Million USD | 26.637% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 73.69% |
| Quipt Home Medical Corp. | 136.29 Million USD | 77.999% |
| IRadimed Corporation | 20.73 Million USD | -44.606% |
| Tenon Medical, Inc. | 5.56 Million USD | -438.629% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -739.459% |
| Pulmonx Corporation | 60.63 Million USD | 50.548% |
| iCAD, Inc. | 8 Million USD | -274.772% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -136.283% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1522.669% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 26.489% |
| SI-BONE, Inc. | 61.05 Million USD | 50.884% |
| Semler Scientific, Inc. | 6.27 Million USD | -378.237% |
| Biotricity, Inc. | 35.91 Million USD | 16.52% |
| DexCom, Inc. | 4.19 Billion USD | 99.285% |
| ZimVie Inc. | 795.85 Million USD | 96.232% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1109.262% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -150.755% |
| IceCure Medical Ltd | 4.24 Million USD | -606.039% |
| PAVmed Inc | 57.13 Million USD | 47.52% |
| Sight Sciences, Inc. | 46.43 Million USD | 35.426% |
| Insulet Corporation | 1.85 Billion USD | 98.384% |
| Profound Medical Corp. | 12.66 Million USD | -136.742% |
| electroCore, Inc. | 8.94 Million USD | -235.22% |
| Bioventus Inc. | 589.79 Million USD | 94.916% |
| InspireMD, Inc. | 8.14 Million USD | -268.281% |
| PAVmed Inc. | 57.13 Million USD | 47.52% |
| Nuwellis, Inc. | 6.78 Million USD | -342.264% |
| OrthoPediatrics Corp. | 72.56 Million USD | 58.675% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -150.755% |
| BrainsWay Ltd. | 15.31 Million USD | -95.804% |
| BIOLASE, Inc. | 35.34 Million USD | 15.171% |
| Beyond Air, Inc. | 29.77 Million USD | -0.707% |
| AxoGen, Inc. | 101.16 Million USD | 70.359% |
| Inari Medical, Inc. | 209.32 Million USD | 85.675% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1271.823% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1585.524% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.049% |
| Quanterix Corporation | 78.08 Million USD | 61.598% |
| Viveve Medical, Inc. | 10.84 Million USD | -176.44% |
| LivaNova PLC | 1.15 Billion USD | 97.397% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -70.042% |
| Varex Imaging Corporation | 668.6 Million USD | 95.515% |
| Vivani Medical, Inc. | 25.03 Million USD | -19.769% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -637.831% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -739.459% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -513.827% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.13% |
| TransMedics Group, Inc. | 568.84 Million USD | 94.729% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -79.747% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2149.263% |
| Spectral AI, Inc. | 12.4 Million USD | -141.799% |
| Hyperfine, Inc. | 9.8 Million USD | -205.974% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 88.018% |
| Biomerica, Inc. | 2.66 Million USD | -1026.003% |
| Bone Biologics Corporation | 831.4 Thousand USD | -3506.615% |
| AVITA Medical, Inc. | 19.86 Million USD | -50.943% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1419.265% |
| Silk Road Medical, Inc | 114.15 Million USD | 73.733% |